Add To Cart

Section 6
Diversion Risk: What is the Treatment Need Versus
the Diversion Risk for Opioid Use Disorder Treatment?

Question 6 | Test | Table of Contents

National Institute on Drug Abuse 

If you wish to increase the text size of this publication, maximize your window.
Click outside the box below, press Ctrl “+” several times, then scroll.
Questions? Email: info@mentalhealthce.com

- National Institute on Drug Abuse. (June 2018). Medications to Treat Opioid Use Disorder Research Report. National Institute on Drug Abuse, p. 19-23.

Peer-Reviewed Journal Article References:
Chavez, M. N., & Rigg, K. K. (2020). Nutritional implications of opioid use disorder: A guide for drug treatment providers. Psychology of Addictive Behaviors, 34(6), 699–707.

De Nadai, A. S., Little, T. B., McCabe, S. E., & Schepis, T. S. (2019). Diverse diagnostic profiles associated with prescription opioid use disorder in a nationwide sample: One crisis, multiple needs. Journal of Consulting and Clinical Psychology, 87(10), 849–858. 

Oliva, E. M., Bowe, T., Tavakoli, S., Martins, S., Lewis, E. T., Paik, M., Wiechers, I., Henderson, P., Harvey, M., Avoundjian, T., Medhanie, A., & Trafton, J. A. (2017). Development and applications of the Veterans Health Administration’s Stratification Tool for Opioid Risk Mitigation (STORM) to improve opioid safety and prevent overdose and suicide. Psychological Services, 14(1), 34–49. 

QUESTION 6
Methadone diversion is primarily associated with Methadone prescribed to treat pain and not treat opioid use disorders. What are the three requirements in Opioid treatment programs? To select and enter your answer go to Test
.


Test
Table of Contents
Top